AAAAAA

   
Results: 1-24 |
Results: 24

Authors: ANDREYEV HJN NORMAN AR CUNNINGHAM D OATES JR CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN PATIENTS WITH COLORECTAL-CANCER - THE MULTICENTER RASCAL STUDY, Journal of the National Cancer Institute, 90(9), 1998, pp. 675-684

Authors: ANDREYEV HJN NORMAN AR OATES J CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, European journal of cancer, 34(4), 1998, pp. 503-509

Authors: TILSED JVT ANDREYEV HJN CUNNINGHAM D CLARKE PA
Citation: Jvt. Tilsed et al., RAS PATHWAYS IN COLORECTAL-CANCER, British Journal of Surgery, 85, 1998, pp. 83-83

Authors: ANDREYEV HJN TILSED JVT CUNNINGHAM D SAMPSON SA NORMAN AR SCHNEIDER HJ CLARKE PA
Citation: Hjn. Andreyev et al., K-RAS MUTATIONS IN PATIENTS WITH EARLY COLORECTAL CANCERS, Gut, 41(3), 1997, pp. 323-329

Authors: ANDREYEV HJN CUNNINGHAM D
Citation: Hjn. Andreyev et D. Cunningham, MICROMETASTASES - ARE THEY CLINICALLY SIGNIFICANT DISEASE - COMMENTARY, Gut, 40(4), 1997, pp. 555-556

Authors: ANDREYEV HJN NORMAN AR OATES J CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, Gut, 40, 1997, pp. 73-73

Authors: ANDREYEV HJN ROSS PJ CUNNINGHAM D CLARKE PA
Citation: Hjn. Andreyev et al., EFFECTIVE TARGETING OF COLORECTAL-CANCER KIRSTEN RAS POINT MUTATIONS WITH ANTISENSE THERAPY IN-VITRO, Gut, 40, 1997, pp. 178-178

Authors: ANDREYEV HJN NORMAN AR CUNNINGHAM D OATES J CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN 2,667 PATIENTS WITH COLORECTAL-CANCER - RESULTS OF THE RASCAL (RAS COLLABORATIVE) PROJECT, Gut, 40, 1997, pp. 193-193

Authors: ANDREYEV HJN NORMAN AR OATES J CUNNINGHAM D
Citation: Hjn. Andreyev et al., WHY DO PATIENTS WITH WEIGHT-LOSS HAVE A WORSE OUTCOME WHEN UNDERGOINGCHEMOTHERAPY FOR GASTROINTESTINAL MALIGNANCIES, Gastroenterology, 112(4), 1997, pp. 532-532

Authors: ANDREYEV HJN ROSS PJ CUNNINGHAM D CLARKE PA
Citation: Hjn. Andreyev et al., EFFECTIVE TARGETING OF COLORECTAL-CANCER KIRSTEN RAS POINT MUTATIONS WITH ANTISENSE THERAPY IN-VITRO, Gastroenterology, 112(4), 1997, pp. 532-532

Authors: ANDREYEV HJN NORMAN AR CUNNINGHAM D OATES J CLARKE PA
Citation: Hjn. Andreyev et al., KIRSTEN RAS MUTATIONS IN 2,667 PATIENTS WITH COLORECTAL-CANCER - RESULTS OF THE RASCAL (RAS COLLABORATIVE) PROJECT, Gastroenterology, 112(4), 1997, pp. 532-532

Authors: SCHNEIDER HJ SAMPSON SA CUNNINGHAM D NORMAN AR ANDREYEV HJN TILSED JVT CLARKE PA
Citation: Hj. Schneider et al., BCL-2 EXPRESSION AND RESPONSE TO CHEMOTHERAPY IN COLORECTAL ADENOCARCINOMAS, British Journal of Cancer, 75(3), 1997, pp. 427-431

Authors: ANDREYEV HJN KAMM MA FORBES A NICHOLLS RJ
Citation: Hjn. Andreyev et al., JOINT SYMPTOMS AFTER RESTORATIVE PROCTOCOLECTOMY IN ULCERATIVE-COLITIS AND FAMILIAL POLYPOSIS-COLI, Journal of clinical gastroenterology, 23(1), 1996, pp. 35-39

Authors: ANDREYEV HJN TILSED JVT CUNNINGHAM D SAMPSON SA NORMAN AR SCHNEIDER HJ CLARKE P
Citation: Hjn. Andreyev et al., MUTATIONS IN CODON-12 AND CODON-13 OF THE KIRSTEN-RAS GENE ARE NOT RELATED TO RELAPSE IN PATIENTS WITH EARLY COLORECTAL CANCERS, Gastroenterology, 110(4), 1996, pp. 484-484

Authors: CLARKE PA SCHNEIDER HJ CUNNINGHAM D NORMAN AR SAMPSON SA TILSED JVT ANDREYEV HJN
Citation: Pa. Clarke et al., BCL-2 EXPRESSION DOES NOT INFLUENCE RESPONSE TO CHEMOTHERAPY IN COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 504-504

Authors: TILSED JVT ANDREYEV HJN CUNNINGHAM D NORMAN AR SCHNEIDER HJ SAMPSON SA CLARKE P
Citation: Jvt. Tilsed et al., CD44V6 EXPRESSION DOES NOT PREDICT OUTCOME IN EARLY COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 603-603

Authors: ANDREYEV HJN
Citation: Hjn. Andreyev, SECRECY IN THE NHS - TITLE IS SENSATIONALIST AND INACCURATE, BMJ. British medical journal, 310(6973), 1995, pp. 190-190

Authors: ANDREYEV HJN NORMAN AR CUNNINGHAM D PADHANI AR HILL AS ROSS PJ WEBB A
Citation: Hjn. Andreyev et al., SQUAMOUS ESOPHAGEAL CANCER CAN BE DOWNSTAGED USING PROTRACTED VENOUS INFUSION OF 5-FLUOROURACIL WITH EPIRUBICIN AND CISPLATIN (ECF), European journal of cancer, 31A(13-14), 1995, pp. 2209-2214

Authors: ANDREYEV HJN SCOTTMACKIE P CUNNINGHAM D NICOLSON V NORMAN AR BADVE SS IVESON A NICOLSON MC
Citation: Hjn. Andreyev et al., PHASE-II STUDY OF CONTINUOUS-INFUSION FLUOROURACIL AND INTERFERON ALFA-2B IN THE PALLIATION OF MALIGNANT NEUROENDOCRINE TUMORS, Journal of clinical oncology, 13(6), 1995, pp. 1486-1492

Authors: ANDREYEV HJN KAMM MA NICHOLLS RJ FORBES A
Citation: Hjn. Andreyev et al., ARTHROPATHY OF INFLAMMATORY BOWEL-DISEASE AND THE EFFECT OF RESTORATIVE PROCTOCOLECTOMY, Gastroenterology, 108(4), 1995, pp. 770-770

Authors: ANDREYEV HJN OWEN RA THOMPSON I FORBES A
Citation: Hjn. Andreyev et al., ASSOCIATION BETWEEN MECKELS-DIVERTICULUM AND CROHNS-DISEASE - A RETROSPECTIVE REVIEW, Gut, 35(6), 1994, pp. 788-790

Authors: ANDREYEV HJN OWEN RA THOMAS PA WRIGHT PL FORBES A
Citation: Hjn. Andreyev et al., ACID-SECRETION FROM A MECKELS-DIVERTICULUM - THE UNSUSPECTED MIMIC OFCROHNS-DISEASE, The American journal of gastroenterology, 89(9), 1994, pp. 1552-1554

Authors: ANDREYEV HJN DEARNALEY DP HORWICH A
Citation: Hjn. Andreyev et al., TESTICULAR NONSEMINOMA WITH HIGH SERUM HUMAN CHORIONIC-GONADOTROPIN -THE TROPHOBLASTIC TERATOMA SYNDROME, Diagnostic oncology, 3(2), 1993, pp. 67-71

Authors: ANDREYEV HJN FORBES A
Citation: Hjn. Andreyev et A. Forbes, PARENTERAL-NUTRITION IN ADULT INTENSIVE-CARE, Postgraduate medical journal, 69(817), 1993, pp. 841-845
Risultati: 1-24 |